NCT05684523: Feasibility Study on the Use of Redormin®500 on Day-time Cognition |
|
|
| Completed | 4 | 40 | Europe | Valerian-Hop Extract, Redormin® 500, Placebo | Max Zeller Soehne AG, University of Basel | Sleep Disorders, Circadian Rhythm, Cognitive Dysfunction | 12/23 | 12/23 | | |